ADVERTISEMENT
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
18 Sep 2020, 10:06 AM IST 
Dr Reddy's Labs Share Price: The stock was among the top boosts to the NSE Nifty 50 index
Dr.Reddy's Laboratories shares surged more than 5 per cent to a record high on Friday, after the Hyderabad-based drug maker said it had settled a patent litigation with US-based Bristol-Myers Squibb's unit, Celgene, over cancer treatment Revlimid. The Dr Reddy's stock jumped by Rs 263.05 (5.45 per cent) to quote at Rs 5,089.65 apiece on the BSE in early deals, having begun the day stronger at Rs 5,001.00 compared to its previous clos...
